A Study of Copanlisib in Combination with Degarelix in People with Prostate Cancer

NCT06218667 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study drug not available per sponsor

Conditions

Prostate Cancer

Interventions

DRUG: Copanlisib
DRUG: Degarelix
PROCEDURE: Radical Prostatectomy

Sponsor

Memorial Sloan Kettering Cancer Center